Gastrointestinal

gastrointestinal

GORD

Top tips: dyspepsia

2018-01-24T14:32:00+00:00By

Dr Sophie Nelson provides 10 top tips for the assessment and management of dyspepsia in adults in primary care

barrett kevin

A multidisciplinary approach is key to best treatment of IBD

2016-09-16T00:00:00+01:00By

Dr Kevin Barrett discusses the diagnosis of inflammatory bowel disease and how implementing quality standards can improve care for patients

stevens richard

Positive diagnosis is a vital first step in the management of IBS

2016-06-03T00:00:00+01:00By Dr Richard Stevens

Dr Richard Stevens discusses how the NICE quality standard for irritable bowel syndrome aims to improve diagnosis, provision of dietary advice, and patient reviews

More articles on gastrointestinal topics

Test and reflect

Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.

Inflammatory bowel disease

2017-11-29T10:04:00+00:00

This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on inflammatory bowel disease (IBD) in primary care—you will then be prompted to reflect on your learning.

More from Guidelines Learning

Educational resources

Formulary decision guide: Semglee (insulin glargine biosimilar)

Formulary decision guide: Hulio® ▼ (adalimumab biosimilar)

2018-10-31T09:24:00+00:00Commissioned by Mylan

Information intended for healthcare professionals only.

Peptac FDG thumbnail

Formulary decision guide: Peptac® (sodium bicarbonate, sodium alginate, calcium carbonate)

2018-10-25T09:30:00+01:00Commissioned by Teva UK Limited

Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional.

Biosimilars-animation-placeholder

Animation on biosimilars: opportunities, evidence, and guidance

2018-06-07T10:10:00+01:00Commissioned by Napp Pharmaceuticals Limited

This Guidelines in Practice animation has been commissioned and funded by Napp Pharmaceuticals Limited and developed in partnership with Guidelines in Practice. Napp Pharmaceuticals Limited suggested the topic for the animation, worked with MGP Ltd to choose and commission the presenter, and approved all materials related to the animation. The ...

20180207 PLENVU FDG

Formulary decision guide: PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, electrolytes)

2018-02-07T10:54:00+00:00Commissioned by Norgine Pharmaceuticals Limited

Commissioned by Norgine Pharmaceuticals Ltd

Related Guidelines summaries

  • Sexual and reproductive health with IBD guideline

    Tue, 17 Jul 2018 09:05 GMT

    Inflammatory bowel disease usually presents during the reproductive years. This concise summary covers fertility, pregnancy, and contraceptive use.

  • Pancreatic exocrine insufficiency guideline

    Mon, 14 May 2018 08:00 GMT

    What are the signs of pancreatic exocrine insufficiency in diabetes? This concise management algorithm covers symptoms, investigations, and referral.

  • UEG pancreatitis guideline

    Tue, 02 Jan 2018 20:59 GMT

    This summary provides recommendations on diagnosing chronic pancreatitis, medical therapy for exocrine pancreatic insufficiency, and pancreatic pain

  • PHE Helicobacter pylori in dyspepsia guideline

    Tue, 03 Jan 2017 00:00 GMT

    A brief summary of PHE's guidance on the testing and treatment of H. pylori in dyspepsia. Includes useful algorithms for testing and treatment regimens.

  • NICE Crohn’s disease guideline

    Mon, 06 Jun 2016 00:00 GMT

    A clear guideline summary on the management of Crohn's disease in adults, children, and young people.